Javascript must be enabled to continue!
33. Functional Study of ELMO-1 Genetic Variant in Diabetes Mellitus Type II and Diabetic Nephropathy
View through CrossRef
Introduction: Engulfment and Cell Motility (ELMO-1) genetic variation was strong candidate of genetic risk for diabetic nephropathy (DN). Several previous study reported genetic variation in intron of ELMO-1 gene as DN risk factor but the study reported genetic variation in promoter of this gene still limited. Genetic variation in promoter of gene promises as diseases risk factor, that may correlate with the functional of genetic variant, whereas difference genotype has difference protein level.
Aims: This study was functional genetic variant study which revealed functional of three ELMO-1 genetic variation in promoter. The difference of protein ELMO-1 protein level between genotype was investigated.
Methods: Study design was cross sectional. Totally 74 patients with DM type II which full filled study criteria was participated, as much 43 patients have DN. We investigated 3 genetic variation in ELMO-1 promoter with Sanger sequencing. The genetic variants were ELMO-1 rs1882071 G/T, rs13242914 C/T, rs13242348 A/G. Blood ELMO-1 was measure with Enzyme-linked Immunosorbent Assay (ELISA).
Result: Subject who suffered DM type II with GG genotype of rs1882071 has higher mean ELMO-1 blood level than GT and TT genotype (p value 0.735). Subject with TT genotype of rs13242914 has higher mean ELMO-1 blood level than CT and CC genotype (p value 0.511). Subject with GG genotype of rs13242348 has higher mean ELMO-1 blood level than AG and AA genotype (p value 0.634). Similar trends also shown in subject who suffered diabetic nephropathy as renal complication of DM type II with p value (0.846; 0.230; 0.847) respectively for rs1882071 G/T, rs13242914 C/T, rs13242348 A/G.
Conclusion: Blood protein ELMO-1 level was difference between genotype in subject who suffered DM type II or with DN complication. None of them was statistically significant, it may cause by other genetic variation or other factor that may influence blood ELMO-1 level.
Ovid Technologies (Wolters Kluwer Health)
Title: 33. Functional Study of ELMO-1 Genetic Variant in Diabetes Mellitus Type II and Diabetic Nephropathy
Description:
Introduction: Engulfment and Cell Motility (ELMO-1) genetic variation was strong candidate of genetic risk for diabetic nephropathy (DN).
Several previous study reported genetic variation in intron of ELMO-1 gene as DN risk factor but the study reported genetic variation in promoter of this gene still limited.
Genetic variation in promoter of gene promises as diseases risk factor, that may correlate with the functional of genetic variant, whereas difference genotype has difference protein level.
Aims: This study was functional genetic variant study which revealed functional of three ELMO-1 genetic variation in promoter.
The difference of protein ELMO-1 protein level between genotype was investigated.
Methods: Study design was cross sectional.
Totally 74 patients with DM type II which full filled study criteria was participated, as much 43 patients have DN.
We investigated 3 genetic variation in ELMO-1 promoter with Sanger sequencing.
The genetic variants were ELMO-1 rs1882071 G/T, rs13242914 C/T, rs13242348 A/G.
Blood ELMO-1 was measure with Enzyme-linked Immunosorbent Assay (ELISA).
Result: Subject who suffered DM type II with GG genotype of rs1882071 has higher mean ELMO-1 blood level than GT and TT genotype (p value 0.
735).
Subject with TT genotype of rs13242914 has higher mean ELMO-1 blood level than CT and CC genotype (p value 0.
511).
Subject with GG genotype of rs13242348 has higher mean ELMO-1 blood level than AG and AA genotype (p value 0.
634).
Similar trends also shown in subject who suffered diabetic nephropathy as renal complication of DM type II with p value (0.
846; 0.
230; 0.
847) respectively for rs1882071 G/T, rs13242914 C/T, rs13242348 A/G.
Conclusion: Blood protein ELMO-1 level was difference between genotype in subject who suffered DM type II or with DN complication.
None of them was statistically significant, it may cause by other genetic variation or other factor that may influence blood ELMO-1 level.
Related Results
Applying Logistic Regression to Predict Diabetic Nephropathy Based on Some Clinical and Paraclinical Characteristics of Type 2 Diabetic Patients
Applying Logistic Regression to Predict Diabetic Nephropathy Based on Some Clinical and Paraclinical Characteristics of Type 2 Diabetic Patients
Today, the incidence of type 2 diabetes mellitus is increasing rapidly on global. This disease is shown with many complications that significantly affect public health. One of them...
PENURUNAN KADAR GULA DARAH DAN RESIKO ULKUS PADA PENDERITA DIABETES MELLITUS DENGAN SENAM KAKI DIABETES
PENURUNAN KADAR GULA DARAH DAN RESIKO ULKUS PADA PENDERITA DIABETES MELLITUS DENGAN SENAM KAKI DIABETES
ABSTRAKDiabetes mellitus adalah suatu penyakit dengan peningkatan glukosa darah di atas normal. Indonesia merupakan negara menempati urutan ke 7 dengan penderita diabetes mellitus ...
Diabetic Nephropathy: Advancement in Molecular Mechanism, Pathogenesis, and Management by Pharmacotherapeutics and Natural Compounds
Diabetic Nephropathy: Advancement in Molecular Mechanism, Pathogenesis, and Management by Pharmacotherapeutics and Natural Compounds
The primary cause of End-stage Renal Disease (ESRD) and a possible chronic microvascular
consequence of diabetes mellitus is Diabetic Nephropathy (DN). The early stages of diabetic...
The Number of Teeth Is Associated with Diabetic Nephropathy
The Number of Teeth Is Associated with Diabetic Nephropathy
Background: Progression of diabetic nephropathy has serious effects on the life expectancy of diabetic patients. Although diagnoses, lifestyle interventions, and treatment of diabe...
Transcription factor 7 like 2 gene polymorphism and advanced glycation end products as risk factors for diabetic nephropathy
Transcription factor 7 like 2 gene polymorphism and advanced glycation end products as risk factors for diabetic nephropathy
Diabetic nephropathy (DN) is the most serious and prevalent complication, being a major contributing factor to end-stage renal disease, that can lead to death in diabetic patients....
Analysis of coping type II diabetes mellitus
Analysis of coping type II diabetes mellitus
Diabetes mellitus is a chronic disease that is a major health and social problem worldwide. This study aims to assess the coping process of patients with type II Diabetes Mellitus ...
CD4 and CXCR5 in Patients with Diabetic Nephropathy
CD4 and CXCR5 in Patients with Diabetic Nephropathy
Background: Diabetes is a metabolic condition characterized by hyperglycemia caused by defects in insulin secretion, insulin activity, or both. Diabetic nephropathy (DN) is one of ...
MO623: Risk Factors of Diabetic Nephropathy Among Newly Detected Type 2 Diabetic Subjects: Preliminary Report from A Tertiary Care Hospital of Bangladesh
MO623: Risk Factors of Diabetic Nephropathy Among Newly Detected Type 2 Diabetic Subjects: Preliminary Report from A Tertiary Care Hospital of Bangladesh
Abstract
BACKGROUND AND AIMS
Patients with type 2 diabetes mellitus may present with different macro- and micro-vascular complic...

